Abstract
Estonia regained independence in 1991 after five decades of occupation by the Soviet Union. The present population-based survey was carried out over five consecutive 5-year study periods (1982–2006) on the incidence and survival of de novo acute leukemia patients aged ≥65 years at diagnosis in Estonia and in a well-defined area in western Sweden. During the study period of retrospective work (1982–1996), the first 10 years were carried out while Estonia was still under the mentorship of the Soviet Union. Over these years, Estonian hematologists did not have access to therapeutic measures readily available to Swedish hematologists, and the results for survival for western Swedish patients with acute myeloid leukemia (AML) far exceeded those of their Estonian counterparts. However, the results for acute lymphoblastic leukemia were equally dismal in the two countries. Subsequent prospective population-based studies were carried out during the years 1997–2006. A gradual improvement as to long-term relative survival of the Estonian AML patients was observed. When studying 2002–2006, no difference as regards relative survival at 5 years was anymore present between the two countries. Over the first 20 years of our population-based studies, it was repeatedly observed that the age-standardized incidence rate particularly for de novo AML was considerably higher for the western Swedish as compared to the Estonian cohorts. During the last 5-year study period (2002–2006), no such difference between the two countries was present, indicating that some true changes in the reporting procedure in Estonia had occurred.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Wennström L, Juntikka E-L, Safai-Kutti S, et al. The incidence and survival of acute de novo leukaemias in Estonia and in a well defined region of western Sweden during 1982–1996: a survey of patients aged 16–64 years. Leuk Lymphoma. 2004;45:915–21.
Luik E, Palk K, Everaus H, et al. The incidence and survival of acute de novo leukaemias in Estonia and in a well-defined region of western Sweden during 1982–1996: a survey of patients aged ≥65 years. J Intern Med. 2004;256:79–85.
Wennström L, Safai-Kutti S, Stockelberg D, et al. The incidence and survival of acute de novo leukemias in Estonia and in a well-defined region of western Sweden during 1997–2001: a survey of patients aged 16–64 years. Acta Haematol. 2011;126:176–85.
Palk K, Luik E, Varik M, et al. The incidence and survival of acute de novo leukemias in Estonia and in a well-defined region of western Sweden during 1997–2001: a survey of patients aged ≥65 years. Cancer Epidemiol. 2010;34:24–8.
Bennett JM, Catovsky D, Daniel MT, et al. Proposed revised criteria for the classification of acute myeloid leukaemia. A report of the French–American–British Cooperative Group. Ann Intern Med. 1985;103:620–5.
Cheson BD, Cassileth PA, Head DR, et al. Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia. J Clin Oncol. 1990;8:813–9.
Öst Å, Reizenstein P. Minimal diagnostic criteria for the myelodysplastic syndrome. Leuk Res. 1992;16:9–11.
Vardiman JW, Harris NL, Brunning RD. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood. 2002;100:2292–302.
Juliusson G, Billström R, Gruber A, et al. Attitude towards remission induction for elderly patients with acute myeloid leukemia influences survival. Leukemia. 2006;20:42–7.
Ahmad OE, Boschi-Pinto C, Lopez AD, et al. Age standardization of rates: a new WHO standard. GPE discussion paper series 31. Geneva: World Health Organization; 2001.
StatCorp. Stata statistical software: release 12. College Station, TX: StataCorp LP; 2012.
The World Bank. The development report 1993: investing in health. New York: Oxford University Press; 1993.
The World Bank. Estonia: the transition to a market economy. A World Bank country study. Washington: The World Bank; 1993.
Pierce N. Waste management challenges in Russia, Ukraine, and Estonia. Waste Age. 1993;24:194–202.
Micheli A, Coebergh JW, Mugeno E, et al. European health systems and cancer care. Ann Oncol. 2003;14(suppl 5):41–60.
Taylor PRA, Reid MM, Proctor SJ. Acute lymphoblastic leukemia in the elderly. Leuk Lymphoma. 1994;13:373–80.
Pulte D, Gondos A, Brenner H. Improvement in survival in younger patients with acute lymphoblastic leukemia from the 1980s to the early 21st century. Blood. 2009;113:1408–11.
Pulte D, Gondos A, Brenner H. Improvements in survival of adults diagnosed with acute myeloblastic leukemia in the early 21st century. Haematologica. 2008;93:594–600.
Acknowledgments
The authors wish to thank Dr. Sergei Nazarenko, Clinical Director, and Dr. Vahur Valvere, Head of the Clinic of Oncology and Hematology at the North Estonia Medical Centre, Tallinn, Estonia, for their continuous generous unconditional support throughout the whole study period.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Punab, M., Palk, K., Varik, M. et al. Sequential population-based studies over 25 years on the incidence and survival of acute de novo leukemias in Estonia and in a well-defined region of western Sweden during 1982–2006: a survey of patients aged ≥65 years. Med Oncol 30, 487 (2013). https://doi.org/10.1007/s12032-013-0487-x
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s12032-013-0487-x